Table 2 Clinical relevant changes in variant classification after re-evaluation.

From: Re-evaluation and re-analysis of 152 research exomes five years after the initial report reveals clinically relevant changes in 18%

Family

Affected

Gene

Variant

Inheritance mode

Gene classification

Variant classification

Explains phenotype

Phenotype

MR205

3, m

DARS2

c.228-12 C > G, p.?

AR

established (11 affected from 8 families, 2 publications)

B (BS1,BS2)

no

moderate ID, seizures, cerebral palsy, cerebral atrophy

MR154

2, m

FOXRED1

c.874 G > A, p.(Gly292Arg)

AR

established (8 affected from 7 families, >3 publications, functional analysis)

VUS (PM2,PM3,PP3)

no

moderate ID, seizures, muscular hypotonia

MR-SYR-04

2, f

HACE1

c.402+5 G > A, p.?

AR

established ( >14 affected from >6 families, >2 publications)

VUS (PM2,PM3_Supporting,PP3)

no

severe ID, ataxia, muscular hypotonia, recurrent infections

MR319

2, f

MTHFR

c.199 C > T, p.(Pro67Ser)

AR

established ( >20 affected from >20 families, >2 publications)

VUS (PM2,PM3_Supporting,PP3)

no

severe ID, microcephaly, abnormality of the optic nerve, EEG abnormalities, cerebral atrophy, leukodystrophy

MR081

2, m

TRMT10A

c.348 G > C, p.(Lys116Asn)

AR

established ( >6 affected from >3 families, >3 publications)

VUS (PM2,PM3_Supporting)

no

severe ID, microcephaly, short stature, behavioral abnormality, cerebral calcification

MR326

2, fm

LINS1

c.786_842del, p.(Arg263_Ser281del)

AR

established ( >7 affected from >3 families, >2 publications)

VUS (PM2,PM3_Supporting,PM4)

no

moderate ID, aggressive behavior, stereotypical motor behaviors, strabismus

MR-ER-31711

1, m

UBE3B

c.[1445 T > A;1616T > C], p.[(Leu539Pro;Leu482His)]

AR

established ( >9 affected from >7 families, >2 publications)

VUS (PM2,PM3,PP3)

no

severe ID, feeding problems in infancy, abnormalities of the face, submucous cleft palate, strabismus, deafness, hypoplastic corpus callosum, hydrocephalus

MR058

1, m

SLC6A8

c.644 A > G, p.(Glu215 Gly)

XL

established ( >10 affected from >9 families, >3 publications)

VUS (PM2,PM3_Supporting,PP3)

no

moderate ID, feeding problems in infancy, congenital megacolon

MR-SYR-34

3, fm

ADGRG1

c.64+5G > A, p.?

AR

established ( >12 affected from >12 families, >3 publications)

VUS (PM2,PM3_Supporting)

no

very severe ID, seizures, limb hypertonia, mental deterioration, deafness, cerebral atrophy

MR305

1, m

PIGA

c.1261 G > C, p.(Gly421Arg)

XL

established ( >14 affected from >7 families, >3 publications)

VUS (PM2,PM3_Supporting,PP3)

no

very severe ID, seizures, microcephaly, spasticity, abnormalities of the face, gingival hypertrophy, nystagmus, scaphocephaly, schizencephaly, leukodystrophy, basal ganglia calcification

MR092

2, m

TSEN15

c.346 C > T, p.(His116Tyr)

AR

published candidate (5 affected from 3 families, no functional analysis)

not applicable

not applicable

moderate ID, microcephaly

  1. AR autosomal recessive, EEG electroencephalogram, f female, hemi hemizygous, hom homozygous, ID intellectual disability, m male, mat maternal, VUS variant of uncertain significance, XL X-linked; compare File S3 [12].